🇺🇸 lidocaine infusion in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 15

Most-reported reactions

1. Infusion Related Reaction — 4 reports (26.67%)
2. Dizziness — 2 reports (13.33%)
3. Visual Impairment — 2 reports (13.33%)
4. Blood Pressure Immeasurable — 1 report (6.67%)
5. Chest Pain — 1 report (6.67%)
6. Diplopia — 1 report (6.67%)
7. Dry Mouth — 1 report (6.67%)
8. Dysgeusia — 1 report (6.67%)
9. Dyspnoea — 1 report (6.67%)
10. Electrocardiogram Qt Corrected Interval Prolonged — 1 report (6.67%)

Source database →

Frequently asked questions

Is lidocaine infusion approved in United States?

lidocaine infusion does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for lidocaine infusion in United States?

Medical University of Warsaw is the originator. The local marketing authorisation holder may differ — check the official source linked above.